BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35697957)

  • 1. Automated brain volumetric program measuring regional brain atrophy in diagnosis of mild cognitive impairment and Alzheimer's disease dementia.
    Ryu DW; Hong YJ; Cho JH; Kwak K; Lee JM; Shim YS; Youn YC; Yang DW
    Brain Imaging Behav; 2022 Oct; 16(5):2086-2096. PubMed ID: 35697957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
    Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of visual rating and automated brain volumetry in early detection and differential diagnosis of Alzheimer's disease.
    Mai Y; Cao Z; Zhao L; Yu Q; Xu J; Liu W; Liu B; Tang J; Luo Y; Liao W; Fang W; Ruan Y; Lei M; Mok VCT; Shi L; Liu J;
    CNS Neurosci Ther; 2024 Apr; 30(4):e14492. PubMed ID: 37864441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk estimation before progression to mild cognitive impairment and Alzheimer's disease: an AD resemblance atrophy index.
    Zhao L; Luo Y; Lew D; Liu W; Au L; Mok V; Shi L;
    Aging (Albany NY); 2019 Aug; 11(16):6217-6236. PubMed ID: 31467257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive visual rating scale of brain magnetic resonance imaging: application in elderly subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Jang JW; Park SY; Park YH; Baek MJ; Lim JS; Youn YC; Kim S
    J Alzheimers Dis; 2015; 44(3):1023-34. PubMed ID: 25380589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Arlt S; Buchert R; Spies L; Eichenlaub M; Lehmbeck JT; Jahn H
    Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):335-44. PubMed ID: 22940716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer's Disease in a Clinical Setting: A REMEMBER Study.
    Wittens MMJ; Sima DM; Houbrechts R; Ribbens A; Niemantsverdriet E; Fransen E; Bastin C; Benoit F; Bergmans B; Bier JC; De Deyn PP; Deryck O; Hanseeuw B; Ivanoiu A; Lemper JC; Mormont E; Picard G; de la Rosa E; Salmon E; Segers K; Sieben A; Smeets D; Struyfs H; Thiery E; Tournoy J; Triau E; Vanbinst AM; Versijpt J; Bjerke M; Engelborghs S
    J Alzheimers Dis; 2021; 83(2):623-639. PubMed ID: 34334402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional connectional fingerprints in mild cognitive impairment and Alzheimer's disease patients.
    Son SJ; Kim J; Park H
    PLoS One; 2017; 12(3):e0173426. PubMed ID: 28333946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural changes in the lobar regions of brain in cerebral small-vessel disease patients with and without cognitive impairment: An MRI-based study with automated brain volumetry.
    Liu C; Zhao L; Yang S; Luo Y; Zhu W; Zhu W; Shi L
    Eur J Radiol; 2020 May; 126():108967. PubMed ID: 32268244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
    Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
    Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.
    Mulder ER; de Jong RA; Knol DL; van Schijndel RA; Cover KS; Visser PJ; Barkhof F; Vrenken H;
    Neuroimage; 2014 May; 92():169-81. PubMed ID: 24521851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anteroposterior and primary-to-posterior limbic ratios as MRI-derived volumetric markers of Alzheimer's disease.
    Jiménez-Huete A; Estévez-Santé S;
    J Neurol Sci; 2017 Jul; 378():110-119. PubMed ID: 28566144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural correlates of mild cognitive impairment: A clinicovolumetric study.
    Sheelakumari R; Kesavadas C; Lekha VS; Justus S; Sarma PS; Menon R
    Neurol India; 2018; 66(2):370-376. PubMed ID: 29547157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer's disease?
    Boutet C; Chupin M; Colliot O; Sarazin M; Mutlu G; Drier A; Pellot A; Dormont D; Lehéricy S;
    Neuroradiology; 2012 Dec; 54(12):1321-30. PubMed ID: 22782577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cerebellum shrinks faster than normal ageing in Alzheimer's disease but not in mild cognitive impairment.
    Tabatabaei-Jafari H; Walsh E; Shaw ME; Cherbuin N;
    Hum Brain Mapp; 2017 Jun; 38(6):3141-3150. PubMed ID: 28321950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Quantitative Hippocampal Volumes and Structured Scoring Scales in Predicting Alzheimer Disease Diagnosis.
    Essien M; Lah J; Weinberg BD; Allen JW; Hu R
    AJNR Am J Neuroradiol; 2023 Dec; 44(12):1411-1417. PubMed ID: 38050003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease.
    Ingala S; van Maurik IS; Altomare D; Wurm R; Dicks E; van Schijndel RA; Zwan M; Bouwman F; Schoonenboom N; Boelaarts L; Roks G; van Marum R; van Harten B; van Uden I; Claus J; Wottschel V; Vrenken H; Wattjes MP; van der Flier WM; Barkhof F
    Eur Radiol; 2022 Nov; 32(11):7789-7799. PubMed ID: 35639148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsed Arterial Spin Labeling and Segmented Brain Volumetry in the Diagnostic Evaluation of Frontotemporal Dementia, Alzheimer's Disease and Mild Cognitive Impairment.
    Marterstock DC; Knott MFX; Hoelter P; Lang S; Oberstein T; Kornhuber J; Doerfler A; Schmidt MA
    Tomography; 2022 Jan; 8(1):229-244. PubMed ID: 35076603
    [No Abstract]   [Full Text] [Related]  

  • 20. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P; Qu H; Cai M; Liu W; Gu X; Ma Q
    Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.